Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.0094 | 1 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.019 | 1 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |